CollPlant Biotechnologies (CLGN) Operating Expenses (2017 - 2026)
CollPlant Biotechnologies (CLGN) posted Operating Expenses of $2.87 million for the quarter ended Mar 30, 2026, down 18.3% from $3.52 million a year earlier and down 9.4% from the prior quarter.
CollPlant Biotechnologies (CLGN) Operating Expenses (2017 - 2026) Analysis & Trends
For the trailing twelve months through Mar 30, 2026, Operating Expenses at CollPlant Biotechnologies was $12.53 million, down 21.0% year-over-year; for the year ended Dec 31, 2025, it was $13.02 million, down 19.3% from the prior year.
- Annual Operating Expenses has declined for three consecutive years, though with a five-year compound annual growth rate of 8.3% (years ended Dec 2020 to Dec 2025).
- In prior years, CollPlant Biotechnologies' Operating Expenses was $16.14 million in the year ended Dec 31, 2024 (-2.1%), $16.48 million in the year ended Dec 31, 2023 (-3.0%), $17 million in the year ended Dec 31, 2022 (+25.2%) and $13.57 million in the year ended Dec 31, 2021 (+55.4%).
- The figure for the quarter ended Mar 30, 2026 stands as the lowest quarterly Operating Expenses since the quarter ended Sep 30, 2020.
- On a year-over-year basis, Operating Expenses has declined in each of the last seven quarters, with an average decline of 12.8% over the last eight quarters.
- The strongest year-over-year quarter for Operating Expenses in the past five years was the quarter ended Jun 30, 2021, with growth of 67.3%; the weakest was the quarter ended Jun 30, 2025, with a decline of 24.6%.
- According to Business Quant data, Operating Expenses for the three prior quarters was $3.17 million (quarter ended Dec 31, 2025), $3.32 million (quarter ended Sep 30, 2025) and $3.17 million (quarter ended Jun 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 10.12 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 10.56 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -6.09 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -9.70 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 6.54 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 18.20 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 6.68 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.09 Bn |
| 10 | CollPlant Biotechnologies | 4.95 Mn | 4.95 Mn | -243,000.00 | 2.87 Mn |
Historic Data
| Date | Value |
|---|---|
| Mar 30, 2026 | 2.87 Mn |
| Dec 31, 2025 | 3.17 Mn |
| Sep 30, 2025 | 3.32 Mn |
| Jun 30, 2025 | 3.17 Mn |
| Mar 30, 2025 | 3.52 Mn |
| Dec 31, 2024 | 3.87 Mn |
| Sep 30, 2024 | 4.27 Mn |
| Jun 30, 2024 | 4.21 Mn |
| Mar 31, 2024 | 3.88 Mn |
| Dec 31, 2023 | 4.59 Mn |
| Sep 30, 2023 | 4.37 Mn |
| Jun 30, 2023 | 3.89 Mn |
| Mar 31, 2023 | 3.63 Mn |
| Dec 31, 2022 | 4.67 Mn |
| Sep 30, 2022 | 4.31 Mn |
| Jun 30, 2022 | 4.21 Mn |
| Mar 31, 2022 | 3.80 Mn |
| Dec 31, 2021 | 3.57 Mn |
| Sep 30, 2021 | 3.09 Mn |
| Jun 30, 2021 | 3.33 Mn |
CollPlant Biotechnologies Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-expenses&ticker=CLGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-expenses", "ticker": "CLGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-expenses&ticker=CLGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();